BGI

B Group Inc Portfolio holdings

AUM $135M
1-Year Est. Return 136.77%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+136.77%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$135M
AUM Growth
+$30.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$8.65M
2
+$3.67M
3
+$758K
4
PRAX icon
Praxis Precision Medicines
PRAX
+$323K

Top Sells

1
+$11M
2
+$4.46M
3
+$945K
4
GAME icon
GameSquare
GAME
+$170K
5
SGHT icon
Sight Sciences
SGHT
+$63.9K

Sector Composition

1 Healthcare 100%
2 Communication Services 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
1
ADMA Biologics
ADMA
$2.56B
$44.8M 33.22%
2,457,542
+45,000
CLLS
2
Cellectis
CLLS
$445M
$15.9M 11.77%
3,281,501
PALI icon
3
Palisade Bio
PALI
$402M
$10.6M 7.84%
+4,500,000
TSHA icon
4
Taysha Gene Therapies
TSHA
$1.85B
$9.9M 7.34%
1,800,556
PRAX icon
5
Praxis Precision Medicines
PRAX
$9.54B
$9.8M 7.26%
33,237
+1,737
SGHT icon
6
Sight Sciences
SGHT
$221M
$7.3M 5.41%
920,000
-10,000
ZLAB icon
7
Zai Lab
ZLAB
$2.73B
$7.06M 5.23%
400,000
GPCR icon
8
Structure Therapeutics
GPCR
$3.6B
$6.26M 4.64%
+90,000
ASMB icon
9
Assembly Biosciences
ASMB
$464M
$5.98M 4.43%
175,706
IOVA icon
10
Iovance Biotherapeutics
IOVA
$1.59B
$4.09M 3.03%
1,500,000
SYRE icon
11
Spyre Therapeutics
SYRE
$6.3B
$3.28M 2.43%
100,000
AURA icon
12
Aura Biosciences
AURA
$468M
$3.12M 2.31%
572,576
RARE icon
13
Ultragenyx Pharmaceutical
RARE
$2.44B
$3.1M 2.3%
135,000
ORKA
14
Oruka Therapeutics
ORKA
$3.41B
$2.27M 1.68%
75,000
APGE icon
15
Apogee Therapeutics
APGE
$6.88B
$1.51M 1.12%
20,000
-15,000
AKRO
16
DELISTED
Akero Therapeutics
AKRO
– –
-232,446
GAME icon
17
GameSquare
GAME
$40M
– –
-250,000
INSM icon
18
Insmed
INSM
$31.2B
– –
-158
LLY icon
19
Eli Lilly
LLY
$828B
– –
0
NRXPW icon
20
NRX Pharmaceuticals Warrant
NRXPW
$1.97K
– –
-3,000,000
NVDA icon
21
NVIDIA
NVDA
$4.9T
– –
0
REPL icon
22
Replimune Group
REPL
$179M
– –
0